Page last updated: 2024-11-05

zonisamide and Carcinoma, Squamous Cell

zonisamide has been researched along with Carcinoma, Squamous Cell in 1 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fan, B1
Huang, Y1
Zhang, H2
Chen, T1
Tao, S1
Wang, X1
Wen, S1
Wang, H1
Lin, Z1
Liu, T1
He, T1
Li, X1

Other Studies

1 other study available for zonisamide and Carcinoma, Squamous Cell

ArticleYear
Analysis of genetic profiling, pathomics signature, and prognostic features of primary lymphoepithelioma-like carcinoma of the renal pelvis.
    Molecular oncology, 2022, Volume: 16, Issue:20

    Topics: Ascorbic Acid; Bupropion; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Histone Demethylas

2022